Human Immunodeficiency Virus Rebound after Suppression to <400 Copies/mL during Initial Highly Active Antiretroviral Therapy Regimens, according to Prior Nucleoside Experience and Duration of Suppression-Reference-Cited by-同舟云学术

Human Immunodeficiency Virus Rebound after Suppression to <400 Copies/mL during Initial Highly Active Antiretroviral Therapy Regimens, according to Prior Nucleoside Experience and Duration of Suppression

Published:2002-10-15 Issue:8 Volume:186 Page:1086-1091
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Phillips Andrew N.,Staszewski Schlomo,Lampe Fiona,Youle Michael S.,Klauke Stephan,Bickel Markus,Sabin Caroline A.,Doerr Hans Wilhelm,Johnson Margaret A.,Loveday Clive,Miller Veronica,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/186/8/1086/18007695/186-8-1086.pdf

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy;Journal of Adolescent Health;2017-07

2. Efficacy of Generic Highly Active Antiretroviral Therapy in HIV-1 Infected Individuals in Nigeria;Journal of Immunoassay and Immunochemistry;2014-12

3. True Durability: HIV Virologic Suppression in an Urban Clinic and Implications for Timing of Intensive Adherence Efforts and Viral Load Monitoring;AIDS and Behavior;2014-11-05

4. Optimal multi-drug approaches for reduction of the latent pool in HIV;IFAC Proceedings Volumes;2014

5. Risk Factors for Short-Term Virologic Outcomes Among HIV-Infected Patients Undergoing Regimen Switch of Combination Antiretroviral Therapy;AIDS Research and Human Retroviruses;2012-12